Drug development pipeline sometimes involves intersection of influence, research and profits

Published on November 26, 2012 at 11:35 AM · No Comments

The Washington Post: As Drug Industry's Influence Over Research Grows, So Does The Potential For Bias
[S]ince about the mid-1980s, research funding by pharmaceutical firms has exceeded what the National Institutes of Health spends. ... The billions that the drug companies invest in such experiments help fund the world's quest for cures. But their aim is not just public health. That money is also part of a high-risk quest for profits, and over the past decade corporate interference has repeatedly muddled the nation's drug science, sometimes with potentially lethal consequences (Whoriskey, 11/24).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Posted in: Healthcare News

Tags: ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post